Modified medium-length catheter shows lower complication rates than PICC in advanced cancer patients

A randomized controlled trial compared a modified medium-length catheter to standard peripherally inserted central catheter (PICC) lines in 160 patients with advanced cancer receiving palliative care. The study setting and follow-up duration were not reported. The intervention was a modified medium-length catheter, while the comparator was a standard PICC line. The primary outcome was not specified in the abstract.

Secondary outcomes included venous complications, satisfaction, and costs. Results indicated lower rates of venous thrombosis, bleeding, and catheter infection in the modified catheter group compared to the standard PICC group. Patient satisfaction and costs were also reported as significantly better in the modified catheter group. However, no specific numerical data, effect sizes, absolute numbers, p-values, or confidence intervals were provided for any outcomes.

Safety data reported venous thrombosis, bleeding, and catheter infection as adverse events, but serious adverse events, discontinuations, and tolerability were not reported. The abstract did not list specific study limitations, and funding or conflicts of interest were not reported. The practice relevance suggests the modified catheter may offer better safety, higher satisfaction, and reduced costs, but this is based on an abstract lacking quantitative evidence.

Key limitations include the absence of numerical results, effect sizes, confidence intervals, and a clearly defined primary outcome. The RCT design allows for causal inference, but the certainty is limited by the abstract-only presentation. Clinicians should interpret these findings cautiously until full publication with detailed data is available.